The Efficacy of Nebulized Procaterol Versus Nebulized Salbutamol for the Treatment of Moderate Acute Asthma: a Randomized, Double-blind, Parallel Group Study.

Trial Profile

The Efficacy of Nebulized Procaterol Versus Nebulized Salbutamol for the Treatment of Moderate Acute Asthma: a Randomized, Double-blind, Parallel Group Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Oct 2011

At a glance

  • Drugs Procaterol; Salbutamol
  • Indications Acute asthma
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 01 Oct 2011 Primary endpoint 'Peak-expiratory-flow-rate' has not been met. Difference between treatment groups (3.9%) reached statistical significance (p<0.05) but did not reach pre-specified clinical significance criteria (5%).
    • 08 Oct 2009 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
    • 12 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top